Fallara, Giuseppe http://orcid.org/0000-0001-7872-2650
Larcher, Alessandro
Rosiello, Giuseppe
Raggi, Daniele
Marandino, Laura
Martini, Alberto
Basile, Giuseppe
Colandrea, Gianmarco
Cignoli, Daniele
Belladelli, Federico
Re, Chiara
Musso, Giacomo
Cei, Francesco
Bertini, Roberto
Briganti, Alberto
Salonia, Andrea
Montorsi, Francesco
Necchi, Andrea
Capitanio, Umberto
Article History
Received: 28 May 2022
Accepted: 7 September 2022
First Online: 20 September 2022
Declarations
:
: Necchi reports honoraria from Roche, Merck Sharp & Dohme, AstraZeneca, Janssen Pharmaceuticals and Foundation Medicine; has served as a consultant or advisor for Merck Sharp & Dohme, Bristol-Myers Squibb, Rainier Therapeutics, Roche, Bayer, AstraZeneca, Clovis Oncology, Janssen Pharmaceuticals, Incyte, Seattle Genetics, Astellas Pharma and Rainier Therapeutics; has received research funding from Incyte, Merck Sharp & Dohme (institution), and AstraZeneca (institution); and has received travel funding from Roche, Merck Sharp & Dohme, Astra Zeneca, and Janssen Pharmaceuticals outside the submitted work.
: The study has been conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. The study was approved by the IRCCS San Raffaele Hospital Ethical Committee (protocollo RENE-versione 29/08/2007-Ospedale San Raffaele di Milano).